Streptomycin
Tuberculosis
CommercialHistorical
Key Facts
About Merck
Merck & Co., Inc. is a leading research-intensive biopharmaceutical company founded in 1891 and headquartered in Rahway, New Jersey. With a market valuation of approximately $282 billion, the company has built a legacy of breakthrough medicines and vaccines, including the blockbuster cancer immunotherapy Keytruda and vaccines like Gardasil. Merck operates globally, reaching 92% of the world's countries with its products and serving over 450 million people with medicines and vaccines in 2024.
View full company profileTherapeutic Areas
Other Tuberculosis Drugs
| Drug | Company | Phase |
|---|---|---|
| Isoniazid Oral Solution, USP | CMP Pharma | Approved |